RAZADYNE ER Overview


GALANTAMINE HYDROBROMIDE

  • CAPSULE, EXTENDED RELEASE; ORAL: EQ 16MG BASE

Details about drugs are organized by FDA Application Number (NDA or ANDA or BLA).

FDA applicationDosage FormStrengthMarketing StatusCompany
NDA #021615CAPSULE, EXTENDED RELEASE; ORALEQ 16MG BASEPrescriptionJANSSEN
Click on a application number to view drug details